// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Arginine and glutamate rich 1 is a novel glucocorticoid receptor coactivator involved in gluconeogenesis

Rucha H Patel - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetes

Glucocorticoid

Molecular crosstalk between GR and hepatic liver x receptor ? (LXR?) in glucocorticoid induced hyperglycemia

Ricky Tsai - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

Glucocorticoid

Investigations into the phenotypic expression of endogenous benzodiazepine-like molecules in Leydig cells and implications for their role in steroid biosynthesis

Zoe Brewster - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Human chorionic gonadotropin

STEROID 7ALPHA-HYDROXYLASES: NEUROSTEROIDS ACTIVATION AND CHOLESTEROL CATABOLISM

Alexey V Yantsevich - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Coronary Artery Disease

pregnenolone

Role of ATAD3 in inter-organelle interactions in hormone-induced Leydig cell steroidogenesis

Malena Beth Rone - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

pregnenolone

Hormone-induced Changes in the Lipid Transport and Metabolism Protein Machineries in Steroidogenic Cell Mitochondria

Andrew Stephen Midzak - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Acquired immunodeficiency syndrome

Human chorionic gonadotropin

Phosphorylation of Estrogen Receptor alpha by mTOR

Chrissie Bruce - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

Alora

MECHANISMS OF ACTION OF ANTIESTROGENS

David Cotnoir-White - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

Fulvestrant

Adipocyte-specific Deletion of Janus kinase 2 (JAK2) Leads to Increased Adiposity and Age-related Glucose Intolerance

Cynthia Theresa Luk - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

lipase

Differences in fat mass between transgenic mice expressing native IGFBP-3 and a non-IGF binding mutant: role of brown fat

Xing Hai Yao - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Mecasermin

The motivation to obtain sugar pellets is attenuated in the ghrelin receptor knock-out rat

Logan Seaman - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Tuberculosis

hGH

Development of Multiple Pituitary Hormone Deficiencies (MPHD) in Pediatric Patients Originally Diagnosed with Isolated GH Deficiency (IGHD) due to Organic Causes

Cheri L Deal - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Pituitary Dwarfism

N/A

Gene Expression Networks Associated with Changes in Serum Insulin (Ins), Ins-like Growth Factor-I (IGF-I), and Growth in Growth Hormone (GH)-Treated Children with GH Deficiency (GHD)

Chiara De Leonibus - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

hGH

Patient Characteristics Associated with Readmission for Diabetic Ketoacidosis at U.S. Children's Hospitals

Rajendu Srivastava - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetic ketoacidosis

N/A

The Lin28/let-7 axis regulates pubertal timing in a sex-dependent manner in mice

Gen Shinoda - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Precocious puberty

N/A

The Point Prevalence of Ovulation in a Large Population-based Sample of Spontaneously, Regularly Menstruating Women. The HUNT Study, Norway

Marit Naess - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Coronary Artery Disease

Alora

Down-regulation of Human Placental Growth Hormone Genes, Known Modulators of Maternal Metabolism, in Pregnancies Complicated by Obesity - A Possible Role for C/EBP?

Yan Jin - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Prediabetes

hGH

The ERK1/2 signaling pathway regulates 11?-hydroxysteroid dehydrogenase type 2 expression in human trophoblast cells through a transcriptional mechanism

Kang Sun - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

SP-600125

The effect of atorvastatin on adipose tissue inflammation and dysfunction in women with polycystic ovary syndrome

Stephen L Atkin - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Polycystic Ovary Syndrome

Atorvastatin

The influence of non-esterified fatty acids on the ovarian production of androgens in a context of in vitro fertilisation Preliminary results

A. Gervais - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Polycystic Ovary Syndrome

Androgen Tear

Copyright © 2026. QuantiNova All rights reserved